🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Could new US investment curbs complicate China’s biotech licensing surge?

Global - Asia Archived • October 26, 2026 •
Could new US investment curbs complicate China’s biotech licensing surge?
Chinese biotech firms face fresh headwinds in their global expansion as Washington’s proposed outbound investment restrictions threaten to disrupt deal structures, even though drug licensing agreements remain untouched for now, analysts say.
The US Treasury Department’s draft rules released last week would “make it much harder for Chinese biotech firms to attract direct US investment or enter joint ventures”, according to David Zhang, an analyst at policy research firm Trivium China.
US Treasury...
Source: South China Morning Post | https://www.scmp.com/rss/91/feed - Read Original
"Retirement Health Care"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Adventure is where you chose to go."